Techno Holdings Corp. (THC) proudly announces the official launch of Phiten in the Philippines. This milestone marks a significant step in giving Filipinos access to high-quality, science-backed ...
“Bobby has an impressive track record in franchise development and is the ideal leader who will accelerate the next chapter of our growth,” said Roland Gonzalez, CEO & President of Church’s Texas ...
In accordance with Section 5635 (c) (4) of the Nasdaq Listing Rule and as a material inducement to his appointment as President and Chief Executive Officer of Ideal Power, the independent members of ...
(NASDAQ: SIGI) ("Selective") today announced the appointment of Julie Parsons to its Board of Directors ("Board"), effective November 3, 2025. With Ms. Parsons’ appointment, Selective’s Board will be ...
The five-year deal, valued at roughly $9.7 billion, includes a 20% prepayment and marks a significant step in IREN’s expansion into large-scale artificial intelligence (AI) infrastructure. The company ...
Mahindra Lifespace Developers rallied 5.28% to Rs 406.05 after the company reported consolidated net profit of Rs 47.91 crore in Q2 FY26, compared with net loss of Rs 14.01 crore in corresponding ...
(NYSE: KVUE) today announced financial results for the third quarter ended September 28, 2025. "Throughout the third quarter, our team remained focused on our four operating priorities to drive ...
In a rapidly evolving advertising landscape where consumers are increasingly discerning, adapting to survive is no longer ...
KUCHING: Jaya Tiasa Holdings Bhd is accelerating its oil palm replanting programme, targeting to cultivate 1,743ha for its ...
Almost seven million people have a health condition that has forced them out of work or limited the amount they can do. As ...
Several TV series have dramatically portrayed succession. In “Game of Thrones,” it is often violent and bloody. In “Succession,” it is full of plot twists and drama. In “The Founder,” ...
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...